CRISX | VSCIX | CRISX / VSCIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 27 years | 27 years | - |
Gain YTD | 14.256 | 18.051 | 79% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 86.9M | 167B | 0% |
Annual Yield % from dividends | 1.46 | 1.43 | 102% |
Returns for 1 year | 15.55 | 19.59 | 79% |
Returns for 3 years | 5.72 | 15.81 | 36% |
Returns for 5 years | 5.21 | 53.99 | 10% |
Returns for 10 years | -6.85 | 125.06 | -5% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBDP | 25.15 | N/A | N/A |
iShares iBonds Dec 2024 Term Corp ETF | |||
GCOR | 40.91 | -0.02 | -0.05% |
Goldman Sachs Access US Aggregate Bd ETF | |||
FHYS | 23.16 | -0.02 | -0.07% |
Federated Hermes Short Duration HY ETF | |||
WDNA | 15.23 | -0.05 | -0.33% |
WisdomTree BioRevolution ETF | |||
MBOX | 33.74 | -0.37 | -1.07% |
Freedom Day Dividend ETF |